Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

crizotinib

crizotinib
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Xalkori CAPSULE, ORAL 200 mg, 250 mg      


Comments:

Rare use expected. There are many serious ADRs associated with Crizotinib.  Crizotinib was classified as non-formulary, not stocked, and patient should use home supply if drug is needed.  Defer initiation to after discharge.  This drug is available through several specialty pharmacies only and the hospital cannot specifically order.  Rare use expected.


Reviewed: December 13, 2011


Last updated: Apr. 11, 2024







This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.